Celestica’s robust demand in enterprise markets and AI expansion make it an attractive pick. Check out why CLS stock is a ...

Analysts estimate that Core Laboratories will report an earnings per share (EPS) of $0.15. Core Laboratories bulls will hope ...

Celestica Inc. CLS has lost 10.8% over the past ... Non-GAAP adjusted effective tax rate is forecasted to be approximately 19 ...

Celestica (CLS) is one of the stocks most watched by ... we prioritize appraising the change in the projection of a company's future earnings over anything else. That's because we believe the ...

That’s a profound statement of financial strength. Main Street Data showing CLS’ earnings per share since Q1 2020 That set the stage for a blockbuster FY2024, and now management projects 22% ...

Celestica (CLS) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates -- one ...

Don't miss insights, networking & opportunities this fall. CLS Holdings USA, Inc. (OTCQB: CLSH) (CSE: CLSH) cannabis company operating as Cannabis Life Sciences announced its first quarter ...